Showing results (221-230 of 308) with videos related to
Sort By:
Pageof 31
Cardiology|October 21, 1998
Depressed plasma platelet-activating factor acetylhydrolase in patients presenting with acute myocardial infarctionV L Serebruany, P A Gurbel, S R Murugesan, et al.Journal of Cardiovascular Pharmacology and Therapeutics|March 26, 2013
Aspirin increases nitric oxide formation in chronic stable coronary diseaseScott Hetzel, David DeMets, Ricky Schneider, et al.Lipids|May 6, 2017
Inhibition of Angiotensin II-Induced Cardiac Fibrosis by Atorvastatin in Adiponectin Knockout MiceSun Young Choi, Jong Sung Park, Mee Sook Roh, et al.International Journal of Cardiology|March 1, 1997
Short-term low dose intracoronary diltiazem administered at the onset of reperfusion reduces myocardial infarct sizeW R Herzog, R A Vogel, M L Schlossberg, et al.Kardiologia Polska|June 22, 2013
Matrix metalloproteinases and the activity of their tissue inhibitors in patients with ST-elevation myocardial infarction treated with primary angioplastyWiktor Kuliczkowski, Joanna Urbaniak, Jonas Hallén, et al.American Heart Journal|January 29, 2000
Role of soluble and platelet-bound P-selectin in discriminating cardiac from noncardiac chest pain at presentation in the emergency departmentP A Gurbel, D J Kereiakes, M R Dalesandro, et al.American Journal of Therapeutics|May 7, 2015
Clopidogrel response variability: impact of genetic polymorphism and platelet biomarkers for predicting adverse outcomes poststentingElena Z Golukhova, Mariya N Ryabinina, Naida I Bulaeva, et al.Journal of the American College of Cardiology|January 18, 2005
Variability in platelet responsiveness to clopidogrel among 544 individualsVictor L Serebruany, Steven R Steinhubl, Peter B Berger, et al.Clinical Cardiology|October 9, 2015
Predicting Bleeding Risk by Platelet Function Testing in Patients Undergoing Heart SurgeryWiktor Kuliczkowski, Joanna Sliwka, Jacek Kaczmarski, et al.American Heart Journal|February 22, 2003
Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trialPaul A Gurbel, Charles C Cummings, Christopher R Bell, et al.Pageof 31